Buprenorphine

The OUD Cascade of Care is a public health framework for monitoring population-level outcomes with an emphasis on MOUD initiation and retention. Buprenorphine treatment can be tailored under the Cascade framework based on patient risk level. For instance, patients with active fentanyl use who are naïve to buprenorphine often need more intensive services early in treatment compared to patients entering care already on buprenorphine, whether prescribed or otherwise.

Join our 4-session online case-based learning collaborative series focused on treating opioid use disorder. Delve into best practices on Hospital Based Approaches to OUD and explore real-world cases provided by addiction experts, applying knowledge to practical situations. Each session is presented live online and spans 1.5 hours.

Fentanyl usage remains a critical public health concern in the US, contributing to alarming increases in overdose fatalities. Clinicians, patients, their families, and policymakers often find themselves uncertain about how to address this rapidly evolving landscape of illicit drug supply. This module aims to provide insights into extended-release injectable products and explore clinical strategies for effectively managing patients who use fentanyl.

According to the Centers for Disease Control (CDC), more than 111,000 people died from a drug overdose in the 12-month period ending last September. Unhoused individuals are especially at risk of overdose deaths. Recent studies show that of people experiencing homelessness, drug-overdose accounted for 1 in 4 deaths. As drug-related overdose deaths continue to rise, the need for innovative, early intervention and harm-reducing services are especially relevant. Programs across the country have begun to develop strategies to reduce harm in these at-risk populations. Come join us as we profile one such program that is focused on providing life-saving medications and interventions to unhoused populations.

Is it appropriate to prescribe buprenorphine monoproduct on a case-by-case basis for the treatment of Opioid Use Disorder for management of patients who experience adverse effects from buprenorphine/naloxone (bup/nx; Suboxone, Zubsolv)?

Transitioning from jails and prisons back into the community can be especially difficult for people with opioid use disorders (OUD). Research suggests that opioid use overdose increases dramatically within the first 30 days of citizens returning to the community. Further, individuals recently released from incarceration face a risk of opioid overdose ten times greater than the general public. During these transitions it is critical that people receive seamless and appropriate resources in order to prevent overdose and return to use. This proper transition can help lower health care costs, hospitalizations and emergency department visits, as well as decrease mortality and recidivism for justice-involved individuals, yet at this time only 13 states have sought Medicaid waivers to provide SUD services pre-release. Join us today as we explore how programs can successfully develop services to ensure returning citizens receive appropriate care to address OUD.

Which patients receiving methadone should be considered good candidates for transfer to buprenorphine? How should I transition a patient from methadone to buprenorphine?

View Guidance.

Opioid use disorder is a chronic disease that affects many and can be effectively treated. Evidence-based treatment for opioid use disorder (OUD), as well as harm reduction initiatives, can help individuals maintain in treatment and mitigate risks of relapse. In this episode, we’ll discuss medications for opioid use disorder (MOUD) as well as OUD treatment considerations and standards of care. The discussion will also include barriers that can stand in the way of those seeking treatment.

Oral health is an essential part of overall health. Healthcare professionals who provide care to patients with possible Opioid Use Disorder (OUD) or Substance Use Disorders (SUD) need to be aware of the special considerations this population may experience. Use this resource to learn how dental professionals can identify patients who may be at high-risk for OUD and SUD, while seeking care in the dental setting.